Trial Profile
ZOLEDRONIC ACID, A LONG-ACTING BISPHOSPHONATE, FOR CHRONIC LOW BACK PAIN DUE TO MODIC CHANGES: A RANDOMIZED CONTROLLED TRIAL
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2018
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Acronyms ZAMOD
- 06 May 2016 New trial record